US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

OPUS GENETICS INC

1.00

+0.01001.01%

Volume:779.40K

Turnover:781.43K

Market Cap:59.66M

PE:-0.50

High:1.05

Open:0.9800

Low:0.9302

Close:0.9900

Loading ...

Overview Company News Filings

Company Profile

Company Name:

OPUS GENETICS INC

Exchange:

NASDAQ

Establishment Date:

2018

Employees:

18

Office Location:

8 Davis Drive,Suite 220,Durham,North Carolina,United States

Website:

http://www.ocuphire.com

Zip Code:

27709

Phone:

Fax:

- -

Introduction:

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.

Directors

Name

Position

Chang H. Ahn

Chairman Emeritus, Director and Chief Scientist

Peter Brandt

Chairman of the Board of Directors

Peter Suzdak

Chief Executive Officer and Director

Charles Beever

Director

Kwang Soo Cheong

Director

Mark Carthy

Director

Richard J. Rodgers

Director

Shareholders

Name

Position

Peter Suzdak

Chief Executive Officer and Director

Tae Heum Jeong

Chief Financial Officer and Secretary

Chang H. Ahn

Chairman Emeritus, Director and Chief Scientist

Ely Benaim

Chief Medical Officer

Lisa Nolan

Chief Business Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IRD/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":1,"timestamp":1749153600000,"preClose":0.99,"halted":0,"volume":779395,"delay":0,"floatShares":52711500,"shares":59661197,"eps":-2.017439,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"06-06 05:44:39 EDT","open":0.98,"high":1.05,"low":0.9302,"amount":781432.182651,"amplitude":0.12101,"askPrice":1.04,"askSize":100,"bidPrice":0.9303,"bidSize":80,"shortable":3,"etf":0,"ttmEps":-2.017439,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749216600000},"marketStatusCode":1,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":1,"postHourTrading":{"tag":"盘后","latestPrice":0.941,"preClose":1,"latestTime":"19:58 EDT","volume":34119,"amount":33059.2917,"timestamp":1749167931819},"volumeRatio":0.09062433287255396,"impliedVol":2.1502,"impliedVolPercentile":0.634},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":52711500,"roa":"-45.36%","roe":"-167.55%","lyrEps":-2.153504,"volumeRatio":0.09062433287255396,"shares":59661197,"dividePrice":0,"high":1.05,"amplitude":0.12101,"preClose":0.99,"low":0.9302,"week52Low":0.65,"pbRate":"11.76","psRate":"4.37","week52High":2.18,"institutionHeld":0,"latestPrice":1,"committee":-0.111111,"eps":-2.017439,"divideRate":0,"volume":779395,"delay":0,"ttmEps":-2.017439,"open":0.98,"prevYearClose":1.19,"prevWeekClose":0.9945,"prevMonthClose":0.9945,"prevQuarterClose":0.9818,"fiveDayClose":0.9945,"twentyDayClose":1.02,"sixtyDayClose":0.97},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":560534013,"yearFounded":2018,"employeeNum":18,"address":"8 Davis Drive,Suite 220,Durham,North Carolina,United States","zipCode":"27709","officePhone":"984 884 6030"},"stockCompanyDetail":{"websiteUrl":"http://www.ocuphire.com","stockEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":0.0728},{"period":"3month","weight":0.0016},{"period":"6month","weight":-0.0991},{"period":"1year","weight":-0.4286},{"period":"ytd","weight":-0.1597}],"compareEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":0.0613},{"period":"3month","weight":0.0297},{"period":"6month","weight":-0.0243},{"period":"1year","weight":0.1092},{"period":"ytd","weight":0.0119}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.074201},{"month":2,"riseRate":0.47619,"avgChangeRate":0.057078},{"month":3,"riseRate":0.333333,"avgChangeRate":0.005763},{"month":4,"riseRate":0.4,"avgChangeRate":0.517227},{"month":5,"riseRate":0.619048,"avgChangeRate":4.359031},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.015986},{"month":7,"riseRate":0.35,"avgChangeRate":-0.003257},{"month":8,"riseRate":0.35,"avgChangeRate":-0.024514},{"month":9,"riseRate":0.45,"avgChangeRate":-0.02299},{"month":10,"riseRate":0.25,"avgChangeRate":-0.106096},{"month":11,"riseRate":0.3,"avgChangeRate":-0.065242},{"month":12,"riseRate":0.47619,"avgChangeRate":0.059596}],"exchange":"NASDAQ","name":"OPUS GENETICS INC","nameEN":"OPUS GENETICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":{"directors":[{"name":"Chang H. Ahn","position":"Chairman Emeritus, Director and Chief Scientist"},{"name":"Peter Brandt","position":"Chairman of the Board of Directors"},{"name":"Peter Suzdak","position":"Chief Executive Officer and Director"},{"name":"Charles Beever","position":"Director"},{"name":"Kwang Soo Cheong","position":"Director"},{"name":"Mark Carthy","position":"Director"},{"name":"Richard J. Rodgers","position":"Director"}],"executives":[{"name":"Peter Suzdak","position":"Chief Executive Officer and Director"},{"name":"Tae Heum Jeong","position":"Chief Financial Officer and Secretary"},{"name":"Chang H. Ahn","position":"Chairman Emeritus, Director and Chief Scientist"},{"name":"Ely Benaim","position":"Chief Medical Officer"},{"name":"Lisa Nolan","position":"Chief Business Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"IRD","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-31","symbol":"IRD","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2024-11-12","symbol":"IRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-08-13","symbol":"IRD","fiscalQuarterEnding":"2024/06","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2024-05-10","symbol":"IRD","fiscalQuarterEnding":"2024/03","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744430400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2025-06-05","current":-1.007584,"percent":0.691275,"low":-2.964142,"twenty":-1.393136,"median":-1.233817,"eighty":-0.767038,"high":-0.560128,"avg":-1.227831,"sd":0.502598,"marketCap":59064585},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-05","current":-1.007584,"twenty":-1.393136,"median":-1.233817,"eighty":-0.767038,"marketCap":59064585}],"updateTime":1749199388275}}}